Northwest Biotherapeutics Market Cap

Northwest Biotherapeutics has a market cap or net worth of $413.23 million as of May 13, 2025. Its market cap has decreased by -28.06% in one year.

Market Cap

413.23M

Enterprise Value

494.01M

Revenue

1.38M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.28

Market Cap Chart

Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 413.23M, an increase of 3,916.18%. That is a compound annual growth rate of 17.08%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	413.23M	13.54%
Dec 31, 2024	363.95M	-55.71%
Dec 29, 2023	821.84M	-1.00%
Dec 30, 2022	830.10M	25.14%
Dec 31, 2021	663.34M	-47.13%
Dec 31, 2020	1.25B	870.89%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	712.65M
Tian'an Technology Group	591.73M
Glass House Brands	479.77M
CytoDyn	475.96M
Elite Pharmaceuticals	468.54M
BioStem Technologies	253.81M

Market Cap Rankings